Skip to main content
Market intelligence
WGSHealthcare

GeneDx Holdings Corp insider activity

In the last 90 days, 6 corporate insiders purchased $251,421,319 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$251,421,319
Corporate buyers
6
Latest transaction
Jun 16, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 16, 2026Kevin FeeleyCHIEF FINANCIAL OFFICERSale3,729$60.77$226,597
Jun 16, 2026Katherine StuelandCHIEF EXECUTIVE OFFICERSale10,501$60.77$638,105
Jun 9, 2026Kevin FeeleyCHIEF FINANCIAL OFFICERSale1,266$53.77$68,073